Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 49 results:
Author Title Type [ Year] Filters: Keyword is Kidney Diseases [Clear All Filters]
Kidney health for all: preparedness for the unexpected in supporting the vulnerable..
Kidney Int. 103(3), 436-443.
(2023). Beta-thalassemia: renal complications and mechanisms: a narrative review..
Hematology. 24(1), 426-438.
(2019). Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study..
Transplantation. 103(6), 1224-1233.
(2019). Histological grading in primary membranous nephropathy is essential for clinical management and predicts outcome of patients..
Histopathology. 75(5), 660-671.
(2019). SGLT-2 inhibitors in Diabetic Kidney Disease: What Lies Behind their Renoprotective Properties?.
Curr Med Chem. 26(29), 5564-5578.
(2019). JC polyomavirus replication and associated disease in pediatric renal transplantation: an international CERTAIN Registry study..
Pediatr Nephrol. 33(12), 2343-2352.
(2018). Renal injury progression in autosomal dominant polycystic kidney disease: a look beyond the cysts..
Nephrol Dial Transplant. 33(11), 1887-1895.
(2018). Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens..
Leuk Lymphoma. 58(8), 1832-1839.
(2017). Impaired kidney function evaluated with the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is associated with more severe acute ischemic stroke..
Vasc Med. 22(5), 432-434.
(2017). Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy..
Am J Hematol. 92(7), 632-639.
(2017).
(2017). Managing renal complications in multiple myeloma..
Expert Rev Hematol. 9(9), 839-50.
(2016). Contrast-Induced Nephropathy: An "All or None" Phenomenon?.
Angiology. 66(6), 508-13.
(2015). Short-, mid-, and long-term benefits of peri-procedural high-intensity statin administration in patients undergoing percutaneous coronary intervention..
Curr Med Res Opin. 31(2), 191-5.
(2015). Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy..
Expert Rev Cardiovasc Ther. 13(9), 1059-66.
(2015). Comparison of the impact of open and endovascular abdominal aortic aneurysm repair on renal function..
J Vasc Surg. 60(3), 597-603.
(2014). Pathogenesis and management of intradialytic hypertension..
Curr Hypertens Rev. 10(3), 171-6.
(2014). The putative role of vitamin D in essential hypertension: stepping into the light?.
Am J Hypertens. 27(7), 985-6.
(2014). Renal and cardiac effects of renal sympathetic denervation and carotid baroreceptor stimulation..
Curr Vasc Pharmacol. 12(1), 55-62.
(2014). Renin inhibition in patients with chronic kidney disease: is it conclusively non-indicated?.
J Renin Angiotensin Aldosterone Syst. 15(1), 97-8.
(2014). Can an accessory renal artery be safely covered during endovascular aortic aneurysm repair?.
Interact Cardiovasc Thorac Surg. 17(6), 1025-7.
(2013). Impaired renal function is associated with mortality and morbidity after endovascular abdominal aortic aneurysm repair..
J Vasc Surg. 58(4), 879-85.
(2013). Role of asymmetrical dimethylarginine in the progression of renal disease..
Nephrology (Carlton). 18(1), 11-21.
(2013). Which patients are at risk for kidney dysfunction after hip fracture surgery?.
Clin Orthop Relat Res. 471(12), 3795-802.
(2013). Editorial: should chronic kidney disease be considered as a coronary heart disease equivalent?.
Curr Vasc Pharmacol. 10(3), 374-7.
(2012).